In chemotherapy-induced hemorrhagic cystitis, which metabolite is most likely responsible?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

In chemotherapy-induced hemorrhagic cystitis, which metabolite is most likely responsible?

Explanation:
In chemotherapy-induced hemorrhagic cystitis, a toxic byproduct formed during activation of alkylating agents like cyclophosphamide or ifosfamide is the main culprit. This metabolite, acrolein, is excreted in the urine and irritates the bladder lining, leading to inflammation, mucosal damage, and bleeding. That’s why Mesna is used clinically to bind acrolein in the urine and prevent bladder injury. Other compounds listed aren’t the primary cause of this toxicity in this context: formaldehyde is a different irritant but not the key metabolite driving this condition, and nitrosamines or Benzo[a]pyrene are carcinogens not responsible for this acute hemorrhagic cystitis.

In chemotherapy-induced hemorrhagic cystitis, a toxic byproduct formed during activation of alkylating agents like cyclophosphamide or ifosfamide is the main culprit. This metabolite, acrolein, is excreted in the urine and irritates the bladder lining, leading to inflammation, mucosal damage, and bleeding. That’s why Mesna is used clinically to bind acrolein in the urine and prevent bladder injury. Other compounds listed aren’t the primary cause of this toxicity in this context: formaldehyde is a different irritant but not the key metabolite driving this condition, and nitrosamines or Benzo[a]pyrene are carcinogens not responsible for this acute hemorrhagic cystitis.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy